In this Avera Medical Minute, one patient explains how a team-based approach to his cancer care made all the difference.

Panelists discuss how the treatment landscape has evolved from limited options to include hypomethylating agents and ...

In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive ...

Syndax has received approval from the Food and Drug Administration for a treatment for a type of acute leukemia.

CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, ...

October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from ...

The AMPLIFY study [NCT03836261] did not include patients with del (17p), so that doublet is not relevant. The study that used ...

Acute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in ...

Leukemia is a blood cancer with abnormal white blood cell overproduction, affecting red blood cells and platelets, leading to anemia and infection risks. Diagnosis involves blood tests, bone marrow ...

A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute myeloid leukemia, one of the most aggressive and fatal blood cancers in adults.

Erin Cross, 6, received an experimental treatment to fight leukemia. — -- A cancer-stricken girl from the U.K. is in remission after her family raised $180,000 to get her to the U.S. for an ...